Notes in Chapter_12:_Transplantation

To Subscribe, use this Key

entries per page

Search:

Status	Last Update	Fields
Published	07/07/2024	The most important HLA overall for recipient/donor organ matching in transplant is HLA-{{c1::DR}}
Published	07/07/2024	The primary determinants of organ allocation in the US are {{c2::time}} and {{c1::HLA matching}}
Published	07/07/2024	ABO blood compatibility is generally required for all organ transplants except for {{c1::liver}} transplant
Published	07/07/2024	Cross-matching for organ donation involves mixing recipient {{c1::serum}} with donor {{c1::lymphocytes}}
Published	07/07/2024	A panel reactive antibody (PRA) score greater than {{c1::50}}% is often a contraindication to transplantation
Published	07/07/2024	Mild organ rejection is treated with {{c1::steroids}}
Published	07/07/2024	Severe organ rejection is treated with {{c1::steroids and antibody therapy}}
Published	07/07/2024	The most common malignancy following any transplant is {{c1::squamous cell carcinoma}}
Published	07/07/2024	The second most common malignancy following transplant is {{c1::post-transplant lympho-proliferative disorder (PTLD)}}
Published	07/07/2024	CellCept is a brand name for {{c1::mycophenolate mofetil}}
Status	Last Update	Fields

Showing 1 to 10 of 97 entries